(MENAFN- EIN Presswire)
Pediatric Growth Hormone Deficiency market Forecast
DelveInsight's pediatric Growth Hormone Deficiency Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.
LAS VEGAS, NV, UNITED STATES, January 20, 2025 /EINPresswire / -- The Pediatric Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Pediatric Growth Hormone Deficiency market dynamics.
DelveInsight's“Pediatric Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pediatric Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Pediatric Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Pediatric Growth Hormone Deficiency market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pediatric Growth Hormone Deficiency Market Forecast
Some of the key facts of the Pediatric Growth Hormone Deficiency Market Report:
.The Pediatric Growth Hormone Deficiency market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
.In December 2024, JCR Pharmaceuticals Co., Ltd. (TSE 4552;“JCR”) has announced that the first patient has received a dose in the Phase III clinical trial of JR-142 (INN: redalsomatropin alfa) in Japan, marking a key milestone in the development of this groundbreaking treatment. JR-142 is a long-acting growth hormone therapy being investigated for use in pediatric patients with growth hormone deficiency.
.As per research conducted by Orso and colleagues in 2022, the projected occurrence of growth hormone deficiency (GHD) ranged from 1 in 4,000 to 10,000 among children in Italy's general population.
.Key Pediatric Growth Hormone Deficiency Companies: I-MAB Biopharma, Lumos Pharma, and others
.Key Pediatric Growth Hormone Deficiency Therapies: TJ101, LUM-201, and others
.The Pediatric Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pediatric Growth Hormone Deficiency pipeline products will significantly revolutionize the Pediatric Growth Hormone Deficiency market dynamics.
Request a sample for the Pediatric Growth Hormone Deficiency Market Report:
Pediatric Growth Hormone Deficiency Overview
Pediatric Growth Hormone Deficiency (PGHD) is a condition where the pituitary gland in the brain does not produce enough growth hormone (GH) in children. Growth hormone is essential for the growth and development of bones and tissues, as well as for various metabolic processes in the body.
Pediatric Growth Hormone Deficiency Epidemiology
The Pediatric Growth Hormone Deficiency epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pediatric Growth Hormone Deficiency Epidemiology Segmentation:
The Pediatric Growth Hormone Deficiency market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
.Total Prevalence of Pediatric Growth Hormone Deficiency
.Prevalent Cases of Pediatric Growth Hormone Deficiency by severity
.Gender-specific Prevalence of Pediatric Growth Hormone Deficiency
.Diagnosed Cases of Episodic and Chronic Pediatric Growth Hormone Deficiency
Download the report to understand which factors are driving Pediatric Growth Hormone Deficiency epidemiology trends @ Pediatric Growth Hormone Deficiency Epidemiological Insights
Pediatric Growth Hormone Deficiency Market
The dynamics of the Pediatric Growth Hormone Deficiency market are anticipated to change in the coming years owing to the expected launch of emerging therapies, and others during the forecasted period 2019-2032.
Pediatric Growth Hormone Deficiency Therapies and Companies
.TJ101: I-MAB Biopharma
.LUM-201: Lumos Pharma
Pediatric Growth Hormone Deficiency Market Strengths
.Various approved therapies are available in the market for this condition which can help in successfully treating PGHD.
.The emerging pipeline has some very potential treatments for PGHD.
Pediatric Growth Hormone Deficiency Market Opportunities
.Since the emerging and approved treatments mainly comprise of long-acting hGH, this is a major opportunity for companies to develop novel drugs with innovative mechanism of action for PGHD which will give them an edge in the current market.
Scope of the Pediatric Growth Hormone Deficiency Market Report
.Study Period: 2019–2032
.Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
.Key Pediatric Growth Hormone Deficiency Companies: I-MAB Biopharma, Lumos Pharma, and others
.Key Pediatric Growth Hormone Deficiency Therapies: TJ101, LUM-201, and others
.Therapeutic Assessment: Pediatric Growth Hormone Deficiency current marketed and Pediatric Growth Hormone Deficiency emerging therapies
.Pediatric Growth Hormone Deficiency Market Dynamics: Pediatric Growth Hormone Deficiency market drivers and barriers
.Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
.Pediatric Growth Hormone Deficiency Unmet Needs, KOL's views, Analyst's views, Pediatric Growth Hormone Deficiency Market Access and Reimbursement
Discover more about therapies set to grab major Pediatric Growth Hormone Deficiency market share @ Pediatric Growth Hormone Deficiency Treatment Landscape
Table of Contents
1. Pediatric Growth Hormone Deficiency Market Report Introduction
2. Executive Summary for Pediatric Growth Hormone Deficiency
3. SWOT analysis of Pediatric Growth Hormone Deficiency
4. Pediatric Growth Hormone Deficiency Patient Share (%) Overview at a Glance
5. Pediatric Growth Hormone Deficiency Market Overview at a Glance
6. Pediatric Growth Hormone Deficiency Disease Background and Overview
7. Pediatric Growth Hormone Deficiency Epidemiology and Patient Population
8. Country-Specific Patient Population of Pediatric Growth Hormone Deficiency
9. Pediatric Growth Hormone Deficiency Current Treatment and Medical Practices
10. Pediatric Growth Hormone Deficiency Unmet Needs
11. Pediatric Growth Hormone Deficiency Emerging Therapies
12. Pediatric Growth Hormone Deficiency Market Outlook
13. Country-Wise Pediatric Growth Hormone Deficiency Market Analysis (2019–2032)
14. Pediatric Growth Hormone Deficiency Market Access and Reimbursement of Therapies
15. Pediatric Growth Hormone Deficiency Market drivers
16. Pediatric Growth Hormone Deficiency Market barriers
17. Pediatric Growth Hormone Deficiency Appendix
18. Pediatric Growth Hormone Deficiency Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN20012025003118003196ID1109109508
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.